Deutsche Boerse (DB1) Given a €129.00 Price Target by Royal Bank of Canada Analysts

Share on StockTwits

Royal Bank of Canada set a €129.00 ($150.00) price target on Deutsche Boerse (ETR:DB1) in a report released on Thursday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Other equities research analysts have also issued reports about the company. UBS Group set a €135.00 ($156.98) price objective on Deutsche Boerse and gave the stock a buy rating in a research note on Monday, February 4th. Deutsche Bank set a €126.00 ($146.51) price objective on Deutsche Boerse and gave the stock a buy rating in a research note on Friday, February 1st. HSBC set a €135.00 ($156.98) price objective on Deutsche Boerse and gave the stock a buy rating in a research note on Friday, January 25th. Finally, DZ Bank reiterated a buy rating on shares of Deutsche Boerse in a research note on Thursday, February 14th. Nine research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of €123.85 ($144.02).

ETR:DB1 opened at €125.50 ($145.93) on Thursday. Deutsche Boerse has a 12 month low of €102.40 ($119.07) and a 12 month high of €122.60 ($142.56). The company has a quick ratio of 0.14, a current ratio of 1.02 and a debt-to-equity ratio of 43.71. The company has a market cap of $23.01 billion and a price-to-earnings ratio of 27.18.

About Deutsche Boerse

Deutsche Börse Aktiengesellschaft operates as an exchange organization in Europe, America, and the Asia-Pacific. The company operates through four segments: Eurex, Xetra, Clearstream, and Market Data + Services. The Eurex segment engages in the electronic trading of European derivatives, commodities, and foreign exchange.

Further Reading: Resistance Level

Analyst Recommendations for Deutsche Boerse (ETR:DB1)

Receive News & Ratings for Deutsche Boerse Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deutsche Boerse and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

HC Wainwright Analysts Give Denali Therapeutics  a $28.00 Price Target
HC Wainwright Analysts Give Denali Therapeutics a $28.00 Price Target
Consolidated-Tomoka Land  Given a $82.00 Price Target by B. Riley Analysts
Consolidated-Tomoka Land Given a $82.00 Price Target by B. Riley Analysts
HC Wainwright Reiterates “$18.00” Price Target for Amicus Therapeutics
HC Wainwright Reiterates “$18.00” Price Target for Amicus Therapeutics
Rapid7  PT Set at $75.00 by Northland Securities
Rapid7 PT Set at $75.00 by Northland Securities
Energy Recovery  Given a $15.00 Price Target at B. Riley
Energy Recovery Given a $15.00 Price Target at B. Riley
MOTIF BIO PLC/S  Given a $5.00 Price Target at Northland Securities
MOTIF BIO PLC/S Given a $5.00 Price Target at Northland Securities


© 2006-2019 Ticker Report